Selective interstitial doxorubicin for recurrent glioblastoma

Poor delimitation from the viable brain, great genetic heterogeneity, lack of tumor vascularisation are factors that preclude intravenous chemotherapy. Interstitial chemotherapy could be a strategy to avoid a blood‐brain barrier and to assure a minimal dose concentration of the chemotherapy agent. D...

Descripción completa

Detalles Bibliográficos
Autores principales: Matcovschii, Valerii, Lisii, Dan, Gudumac, Valentin, Dorosenco, Stanislav
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6935603/
https://www.ncbi.nlm.nih.gov/pubmed/31893093
http://dx.doi.org/10.1002/ccr3.2546

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6935603/
https://www.ncbi.nlm.nih.gov/pubmed/31893093
http://dx.doi.org/10.1002/ccr3.2546

Ejemplares similares